New heart device under watch: belgian registry to track EV-ICD safety and performance
NCT ID NCT07156851
First seen Oct 01, 2025 · Last updated May 22, 2026 · Updated 27 times
Summary
This study will follow about 100 people in Belgium who have received or will receive a new type of implantable defibrillator (EV-ICD) as part of their normal care. Researchers will collect data from medical records to monitor how well the device works, any complications, and patients' quality of life over the device's lifetime. No extra tests or visits are required.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.